nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00516	0.00516	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00516	0.00516	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00516	0.00516	CcSEcCtD
Aztreonam—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00513	0.00513	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00505	0.00505	CcSEcCtD
Aztreonam—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00497	0.00497	CcSEcCtD
Aztreonam—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00497	0.00497	CcSEcCtD
Aztreonam—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00494	0.00494	CcSEcCtD
Aztreonam—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.0049	0.0049	CcSEcCtD
Aztreonam—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.00481	0.00481	CcSEcCtD
Aztreonam—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.0047	0.0047	CcSEcCtD
Aztreonam—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00467	0.00467	CcSEcCtD
Aztreonam—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00465	0.00465	CcSEcCtD
Aztreonam—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00463	0.00463	CcSEcCtD
Aztreonam—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.0045	0.0045	CcSEcCtD
Aztreonam—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00448	0.00448	CcSEcCtD
Aztreonam—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00431	0.00431	CcSEcCtD
Aztreonam—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00417	0.00417	CcSEcCtD
Aztreonam—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00415	0.00415	CcSEcCtD
Aztreonam—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00415	0.00415	CcSEcCtD
Aztreonam—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00407	0.00407	CcSEcCtD
Aztreonam—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00401	0.00401	CcSEcCtD
Aztreonam—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00399	0.00399	CcSEcCtD
Aztreonam—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00396	0.00396	CcSEcCtD
Aztreonam—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00388	0.00388	CcSEcCtD
Aztreonam—Petechiae—Prednisone—chronic obstructive pulmonary disease	0.00386	0.00386	CcSEcCtD
Aztreonam—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00384	0.00384	CcSEcCtD
Aztreonam—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00382	0.00382	CcSEcCtD
Aztreonam—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00381	0.00381	CcSEcCtD
Aztreonam—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00378	0.00378	CcSEcCtD
Aztreonam—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00375	0.00375	CcSEcCtD
Aztreonam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00375	0.00375	CcSEcCtD
Aztreonam—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00372	0.00372	CcSEcCtD
Aztreonam—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00372	0.00372	CcSEcCtD
Aztreonam—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00366	0.00366	CcSEcCtD
Aztreonam—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0036	0.0036	CcSEcCtD
Aztreonam—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00357	0.00357	CcSEcCtD
Aztreonam—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00357	0.00357	CcSEcCtD
Aztreonam—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00356	0.00356	CcSEcCtD
Aztreonam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00355	0.00355	CcSEcCtD
Aztreonam—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00355	0.00355	CcSEcCtD
Aztreonam—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00353	0.00353	CcSEcCtD
Aztreonam—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00345	0.00345	CcSEcCtD
Aztreonam—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00345	0.00345	CcSEcCtD
Aztreonam—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00342	0.00342	CcSEcCtD
Aztreonam—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.00338	0.00338	CcSEcCtD
Aztreonam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Aztreonam—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00327	0.00327	CcSEcCtD
Aztreonam—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00327	0.00327	CcSEcCtD
Aztreonam—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00326	0.00326	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00325	0.00325	CcSEcCtD
Aztreonam—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00322	0.00322	CcSEcCtD
Aztreonam—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00322	0.00322	CcSEcCtD
Aztreonam—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00322	0.00322	CcSEcCtD
Aztreonam—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.0032	0.0032	CcSEcCtD
Aztreonam—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00318	0.00318	CcSEcCtD
Aztreonam—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00318	0.00318	CcSEcCtD
Aztreonam—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00315	0.00315	CcSEcCtD
Aztreonam—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00309	0.00309	CcSEcCtD
Aztreonam—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00309	0.00309	CcSEcCtD
Aztreonam—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00307	0.00307	CcSEcCtD
Aztreonam—Cough—Formoterol—chronic obstructive pulmonary disease	0.00307	0.00307	CcSEcCtD
Aztreonam—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00304	0.00304	CcSEcCtD
Aztreonam—Cough—Montelukast—chronic obstructive pulmonary disease	0.00301	0.00301	CcSEcCtD
Aztreonam—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Aztreonam—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Aztreonam—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Aztreonam—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Aztreonam—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Aztreonam—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Aztreonam—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00299	0.00299	CcSEcCtD
Aztreonam—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00299	0.00299	CcSEcCtD
Aztreonam—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00299	0.00299	CcSEcCtD
Aztreonam—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00299	0.00299	CcSEcCtD
Aztreonam—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00296	0.00296	CcSEcCtD
Aztreonam—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00296	0.00296	CcSEcCtD
Aztreonam—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Aztreonam—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Aztreonam—Cough—Salbutamol—chronic obstructive pulmonary disease	0.0029	0.0029	CcSEcCtD
Aztreonam—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00288	0.00288	CcSEcCtD
Aztreonam—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00288	0.00288	CcSEcCtD
Aztreonam—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Aztreonam—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Aztreonam—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Aztreonam—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00282	0.00282	CcSEcCtD
Aztreonam—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00282	0.00282	CcSEcCtD
Aztreonam—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.0028	0.0028	CcSEcCtD
Aztreonam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00278	0.00278	CcSEcCtD
Aztreonam—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00276	0.00276	CcSEcCtD
Aztreonam—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00276	0.00276	CcSEcCtD
Aztreonam—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Aztreonam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00269	0.00269	CcSEcCtD
Aztreonam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00269	0.00269	CcSEcCtD
Aztreonam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00267	0.00267	CcSEcCtD
Aztreonam—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00267	0.00267	CcSEcCtD
Aztreonam—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00266	0.00266	CcSEcCtD
Aztreonam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00263	0.00263	CcSEcCtD
Aztreonam—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00263	0.00263	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00262	0.00262	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00262	0.00262	CcSEcCtD
Aztreonam—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.0026	0.0026	CcSEcCtD
Aztreonam—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.0026	0.0026	CcSEcCtD
Aztreonam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00259	0.00259	CcSEcCtD
Aztreonam—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00257	0.00257	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00257	0.00257	CcSEcCtD
Aztreonam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Aztreonam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Aztreonam—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00255	0.00255	CcSEcCtD
Aztreonam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00254	0.00254	CcSEcCtD
Aztreonam—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00253	0.00253	CcSEcCtD
Aztreonam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00252	0.00252	CcSEcCtD
Aztreonam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0025	0.0025	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00247	0.00247	CcSEcCtD
Aztreonam—Pain—Formoterol—chronic obstructive pulmonary disease	0.00246	0.00246	CcSEcCtD
Aztreonam—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00246	0.00246	CcSEcCtD
Aztreonam—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00246	0.00246	CcSEcCtD
Aztreonam—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00244	0.00244	CcSEcCtD
Aztreonam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00242	CcSEcCtD
Aztreonam—Pain—Montelukast—chronic obstructive pulmonary disease	0.00241	0.00241	CcSEcCtD
Aztreonam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.0024	0.0024	CcSEcCtD
Aztreonam—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00239	0.00239	CcSEcCtD
Aztreonam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00238	0.00238	CcSEcCtD
Aztreonam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00238	0.00238	CcSEcCtD
Aztreonam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Aztreonam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Aztreonam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Aztreonam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00236	0.00236	CcSEcCtD
Aztreonam—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Aztreonam—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Aztreonam—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Aztreonam—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Aztreonam—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00228	0.00228	CcSEcCtD
Aztreonam—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.00228	CcSEcCtD
Aztreonam—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Aztreonam—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Aztreonam—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Aztreonam—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Aztreonam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Aztreonam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00225	0.00225	CcSEcCtD
Aztreonam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Aztreonam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Aztreonam—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Aztreonam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Aztreonam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Aztreonam—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Aztreonam—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Aztreonam—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Aztreonam—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.0022	0.0022	CcSEcCtD
Aztreonam—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Aztreonam—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00216	CcSEcCtD
Aztreonam—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00215	CcSEcCtD
Aztreonam—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00215	CcSEcCtD
Aztreonam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00212	0.00212	CcSEcCtD
Aztreonam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00212	0.00212	CcSEcCtD
Aztreonam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00212	0.00212	CcSEcCtD
Aztreonam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00208	0.00208	CcSEcCtD
Aztreonam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.00206	CcSEcCtD
Aztreonam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00206	0.00206	CcSEcCtD
Aztreonam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00203	0.00203	CcSEcCtD
Aztreonam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00203	0.00203	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00203	0.00203	CcSEcCtD
Aztreonam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00202	0.00202	CcSEcCtD
Aztreonam—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.002	0.002	CcSEcCtD
Aztreonam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.002	0.002	CcSEcCtD
Aztreonam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00199	0.00199	CcSEcCtD
Aztreonam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00197	0.00197	CcSEcCtD
Aztreonam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00197	0.00197	CcSEcCtD
Aztreonam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Aztreonam—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00194	0.00194	CcSEcCtD
Aztreonam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00193	0.00193	CcSEcCtD
Aztreonam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00192	CcSEcCtD
Aztreonam—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00191	0.00191	CcSEcCtD
Aztreonam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0019	0.0019	CcSEcCtD
Aztreonam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.0019	CcSEcCtD
Aztreonam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Aztreonam—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Aztreonam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Aztreonam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00183	0.00183	CcSEcCtD
Aztreonam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00183	0.00183	CcSEcCtD
Aztreonam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00181	CcSEcCtD
Aztreonam—Rash—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00181	CcSEcCtD
Aztreonam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00181	CcSEcCtD
Aztreonam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00181	CcSEcCtD
Aztreonam—Headache—Formoterol—chronic obstructive pulmonary disease	0.0018	0.0018	CcSEcCtD
Aztreonam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.0018	0.0018	CcSEcCtD
Aztreonam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.0018	CcSEcCtD
Aztreonam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00179	0.00179	CcSEcCtD
Aztreonam—Rash—Montelukast—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Aztreonam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Aztreonam—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Aztreonam—Headache—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Aztreonam—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00174	0.00174	CcSEcCtD
Aztreonam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00173	CcSEcCtD
Aztreonam—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00172	0.00172	CcSEcCtD
Aztreonam—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00171	0.00171	CcSEcCtD
Aztreonam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00171	CcSEcCtD
Aztreonam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00171	CcSEcCtD
Aztreonam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00171	CcSEcCtD
Aztreonam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00171	CcSEcCtD
Aztreonam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.0017	CcSEcCtD
Aztreonam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Aztreonam—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00165	0.00165	CcSEcCtD
Aztreonam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00161	CcSEcCtD
Aztreonam—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00161	0.00161	CcSEcCtD
Aztreonam—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.0016	0.0016	CcSEcCtD
Aztreonam—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00159	0.00159	CcSEcCtD
Aztreonam—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00156	0.00156	CcSEcCtD
Aztreonam—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00151	0.00151	CcSEcCtD
Aztreonam—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00148	0.00148	CcSEcCtD
Aztreonam—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Aztreonam—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.0014	CcSEcCtD
Aztreonam—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00139	0.00139	CcSEcCtD
Aztreonam—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
Aztreonam—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00129	CcSEcCtD
Aztreonam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Aztreonam—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Aztreonam—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Aztreonam—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Aztreonam—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Aztreonam—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00124	0.00124	CcSEcCtD
Aztreonam—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Aztreonam—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Aztreonam—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Aztreonam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Aztreonam—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Aztreonam—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Aztreonam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Aztreonam—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00102	CcSEcCtD
Aztreonam—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00102	CcSEcCtD
Aztreonam—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000982	0.000982	CcSEcCtD
Aztreonam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000981	0.000981	CcSEcCtD
Aztreonam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000976	0.000976	CcSEcCtD
Aztreonam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000933	0.000933	CcSEcCtD
Aztreonam—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000925	0.000925	CcSEcCtD
Aztreonam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000925	0.000925	CcSEcCtD
Aztreonam—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000899	0.000899	CcSEcCtD
Aztreonam—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000895	0.000895	CcSEcCtD
Aztreonam—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000895	0.000895	CcSEcCtD
Aztreonam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000834	0.000834	CcSEcCtD
Aztreonam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000812	0.000812	CcSEcCtD
Aztreonam—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000801	0.000801	CcSEcCtD
Aztreonam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000774	0.000774	CcSEcCtD
Aztreonam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000748	0.000748	CcSEcCtD
Aztreonam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00072	0.00072	CcSEcCtD
Aztreonam—Rash—Prednisone—chronic obstructive pulmonary disease	0.000714	0.000714	CcSEcCtD
Aztreonam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000713	0.000713	CcSEcCtD
Aztreonam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000709	0.000709	CcSEcCtD
Aztreonam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000672	0.000672	CcSEcCtD
